Long Term Results and Complications After Epistaxis Treatment

NCT02127554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 591

Last updated 2015-12-02

No results posted yet for this study

Summary

The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.

Conditions

  • Nosebleed (Epistaxis) - Posterior or Anterior

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Michael Soyka, Dr.med. · Zurich University Hospital

Eligibility

Min Age
14 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02127554 on ClinicalTrials.gov